AgriBusiness Biotech

Zoetis and Danone Partner to Enhance Dairy Sustainability Through Genetic Innovation

Zoetis & Danone announced a joint plan to improve dairy sustainability through genetic technologies for healthier, more resilient cows.
Photo by Neil Bates on Unsplash

Key Takeaways:

  • Zoetis and Danone have announced a joint plan to improve dairy sustainability through genetic technologies for healthier, more resilient cows.
  • The partnership aims to integrate Zoetis’ expertise in genetics with Danone’s environmental stewardship goals to drive long-term sustainability in dairy farming.
  • Zoetis’ genetic testing solutions help predict an animal’s susceptibility to diseases and potential for lifelong health, aligning with Danone’s sustainability objectives.
  • The collaboration supports dairy producers in meeting consumer demand for sustainable practices while enhancing farm profitability and animal welfare.

Zoetis and Danone Collaborate to Drive Sustainability in Dairy Farming through Genetic Technologies

Zoetis and Danone have announced a joint business development plan aimed at promoting sustainable practices in dairy farming by leveraging advances in animal genetics. This collaboration combines Danone’s commitment to environmental stewardship with Zoetis’ expertise in genetic testing, offering an innovative approach to breeding healthier, more resilient dairy cows.

The focus of the partnership is on using Zoetis’ cutting-edge genetic technologies globally to enhance dairy farming practices. By integrating sustainable genetics into breeding and selection processes, the companies aim to improve animal well-being, reduce the environmental impact of dairy farming, and promote long-term farm resilience.

Leveraging Genetics for Sustainability

“Collaborative partnerships allow us to harmonize genetic innovation with sustainable practices. Through our partnership with Danone, we intend to leverage our respective expertise to set new benchmarks for healthier herds that contribute to a sustainable future for the dairy industry,” said Wafaa Mamilli, EVP, Chief Digital & Technology Officer, and Group President for China, Brazil, and Precision Animal Health at Zoetis.

Zoetis’ genetic testing solutions are designed to help predict an animal’s susceptibility to diseases and assess its potential for lifelong productivity. These tools align with Danone’s goal to support environmentally resilient dairy production, helping farmers breed cows that remain healthy and productive while minimizing environmental impact.

Danone’s Commitment to Dairy Sustainability

Jean-Yves Krummenacher, Chief Procurement Officer at Danone, expressed enthusiasm for the partnership, saying, “We really look forward to embarking with Zoetis on this journey. Together, we are committed to utilizing genomic testing as an important tool for incorporating sustainability at its core. This partnership aligns with our vision of creating positive change throughout the dairy value chain.”

Zoetis became a member of Danone’s global Partner for Growth program in 2023, serving as the preferred provider for genetic testing on dairy farms. Zoetis’ Dairy Wellness Profit Index® (DWP$®), available through its CLARIFIDE® Plus platform, provides dairy farmers with a multi-trait selection index to estimate an animal’s potential lifetime profit. This comprehensive tool allows farmers to evaluate traits such as wellness, production, fertility, and milk quality, helping them make informed breeding and culling decisions.


Zoetis Latest News

Phibro Animal Health To Acquire MFA Product Portfolio (2024/04/29)

Zoetis and Phibro Animal Health Corporation have agreed to acquire Zoetis’ medicated feed additive product portfolio and assets for $350 million. The deal, set to close in the second half of 2024, includes over 37 product lines, six manufacturing facilities in the US, Italy, and China, and over 300 Zoetis staff members. Zoetis CEO Kristin Peck believes the move aligns with the company’s strategy to focus on vaccines and genetic programs. Phibro plans to finance the acquisition primarily through debt, with commitments from several banks already in place.

Unveils Monoclonal Antibodies Expansion in Lincoln, NE (2023/08/11)

Zoetis has officially inaugurated its groundbreaking Monoclonal Antibodies (mAbs) expansion facility in Lincoln, Nebraska. The company’s commitment to innovation, quality, and the welfare of animals is reflected in this state-of-the-art facility that promises to revolutionize the treatment of osteoarthritis pain in dogs and cats.

Ester Banque Appointed as Zoetis’ Executive VP and President of U.S. Operations (2023/07/11)

Zoetis Inc. (NYSE: ZTS), a global leader in animal health, has announced the appointment of Ester Banque as the new Executive Vice President and President of U.S. Operations, effective July 10, 2023. Ms. Banque, a seasoned executive with over three decades of experience in health sciences at leading pharmaceutical firms, will join the Zoetis Executive team and directly report to CEO Kristin Peck.

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply